TARP as antigen in cancer immunotherapy

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Immunotherapy is crucial for cancer treatment, but identifying effective targets remains a challenge.
• Cancer-associated antigens are needed for immunotherapeutics with high efficacy and minimal side effects.
• The T-cell receptor gamma (TCRγ) chain alternate reading frame protein (TARP) is a potential cancer antigen.

Purpose of the Study:

• To review the expression patterns of TARP in various cancer types.
• To explore the role of TARP in oncogenesis, including tumor proliferation and migration.
• To summarize current TARP-directed immunotherapeutic strategies.

Main Methods:

• Literature review of studies on TARP expression and function.
• Analysis of TARP's role in different malignancies.
• Overview of ongoing immunotherapeutic approaches targeting TARP.

Main Results:

• TARP is expressed in prostate, breast, endometrial cancers, salivary gland tumors, and acute myeloid leukemia.
• TARP expression correlates with increased tumor cell proliferation, migration, and poorer survival.
• Limited TARP expression in normal tissues suggests therapeutic potential.

Conclusions:

• TARP is a relevant target for cancer immunotherapy due to its expression in malignant cells and role in oncogenesis.
• Further investigation into TARP-directed therapies may lead to improved cancer treatment outcomes.
• TARP-based immunotherapeutics offer a promising avenue for on-target cancer treatment with reduced off-tumor effects.